Ledger.Open graph →
SEC Form D · Amendment · filed December 9, 2016

Oncternal Therapeutics, Inc

Offering
$20.0M
Sold
$11.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Scott L. Glenn · San Diego, CADirectorJames B. Breitmeyer, M.D., Ph.D · San Diego, CAExec · DirectorBrian B. Lannutti · San Diego, CAExecCam L. Garner · San Diego, CADirectorDavid B. Johnson · San Diego, CADirectorDavid F. Hale · San Diego, CADirectorLangdon G. Miller · San Diego, CAExecLauren G. Otsuki · San Diego, CAExecDana B. Mcgowan · San Diego, CAExecCam B. Gallagher · San Diego, CADirectorGene Smestad · Valley City, NDExecThomas A. Roszak · Northfield, ILExecRay Braun · Valley City, NDDirectorStan Johnson · Fargo, NDDirectorGarheng P. Kong · New Haven, CTDirectorBrad Fay · Bismarck, NDExecErin T. Duffy · New Haven, CTExecPaul T. Estrem · New Haven, CTExec · DirectorCraig Lloyd · Sioux Falls, SDDirectorMichael A. Moceri · Chicago, ILDirectorSteven Kay · San Francisco, CAExecMark Jorgensen · San Francisco, CADirectorDenise Woodard · Jersey City, NJDirectorJames F. Corum · Waxahachie, TXExecAllen R. Page · Waxahachie, TXDirectorCalvin E. Webb, Iii · Waxahachie, TXDirectorGayle Troberman · New York, NYDirectorLCM Funds Asset Manager LLC · Milwaukee, WIExecDavid J. Winograd · Milwaukee, WIExec · DirectorMichael Krupka · BOSTON, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗